Stay updated on MRTX1133 in KRAS G12D+ Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the MRTX1133 in KRAS G12D+ Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MRTX1133 in KRAS G12D+ Solid Tumors Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.3%
    Check dated 2025-02-03T08:56:18.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.0 to v2.14.1.
    Difference
    0.3%
    Check dated 2025-01-19T23:26:38.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The website has added a new type of intervention in the latest update (v2.14.0) on January 9, 2025, following the removal of the previous type of intervention in version v2.13.3 on December 16, 2024.
    Difference
    2%
    Check dated 2025-01-12T18:23:04.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The status has changed from 'Recruiting' to 'Active, not recruiting' as of December 16, 2024.
    Difference
    1%
    Check dated 2024-12-22T01:40:43.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.3%
    Check dated 2024-12-14T22:47:56.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.
    Difference
    0.3%
    Check dated 2024-12-07T16:19:41.000Z thumbnail image

Stay in the know with updates to MRTX1133 in KRAS G12D+ Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MRTX1133 in KRAS G12D+ Solid Tumors Clinical Trial page.